Compass PathwaysMEX:CMPSN 14 Forward Dividend Yield % is 0.00% as of Jun. 26, 2026. GuruFocus rates MEX:CMPSN with a GF Score™ of 14/100. The stock has 2 warning signs investors should review. Among 275 Healthcare Providers & Services companies, Compass Pathways ranks worse than 363636% on this metric.
As of today (2026-06-26), the Forward Annual Dividend Yield of Compass Pathways is 0.00%.
As of today (2026-06-26), the Trailing Annual Dividend Yield of Compass Pathways is 0.00%.
MEX:CMPSN's Forward Dividend Yield % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.48 * Ranked among companies with meaningful Forward Dividend Yield % only.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Compass Pathways Forward Dividend Yield % Related Terms
MEX:CMPSN vs MD, SGRY, ADUS: Forward Dividend Yield % Comparison
For the Medical Care Facilities subindustry, Compass Pathways's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Compass Pathways Forward Dividend Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Compass Pathways's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Compass Pathways's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
Compass Pathways (MEX:CMPSN) has a Forward Dividend Yield % of 0.00% as of Jun. 26, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Compass Pathways and its competitors. According to the industry distribution chart, Compass Pathways ranks #999999 out of 275 companies in the Healthcare Providers & Services industry.
Is Compass Pathways' Forward Dividend Yield % too high?
Compass Pathways' current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Compass Pathways ranks #999999 out of 275 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Compass Pathways has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Compass Pathways' Forward Dividend Yield % compare to MD and SGRY?
According to the Healthcare Providers & Services industry distribution chart, Compass Pathways ranks #999999 out of 275 companies for Forward Dividend Yield %. This places Compass Pathways in the lower half of its industry. The industry median Forward Dividend Yield % is 2.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Healthcare Providers & Services company?
The median Forward Dividend Yield % among Healthcare Providers & Services companies is 2.48, based on 275 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Compass Pathways and its competitors. For the Healthcare Providers & Services industry, the median Forward Dividend Yield % is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Compass Pathways's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Compass Pathways stock overvalued right now?
Compass Pathways (MEX:CMPSN) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. Compass Pathways' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Compass Pathways (MEX:CMPSN), the current Forward Dividend Yield % is 0.00% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
14GF Score
Get the complete analysis for MEX:CMPSN
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:CMPSN has been successfully added to your 